• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Changes in urokinase-type plasminogen activator in orthotopic liver transplantation.

作者信息

Himmelreich G, Dooijewaard G, Breinl P, Bechstein W O, Blumhardt G, Kluft C, Riess H

机构信息

Department of Internal Medicine, University Hospital Rudolf Virchow, Berlin, Germany.

出版信息

Semin Thromb Hemost. 1993;19(3):311-4. doi: 10.1055/s-2007-994050.

DOI:10.1055/s-2007-994050
PMID:7689759
Abstract

Elevated levels of u-PA Ag and scu-PA preoperatively and before revascularization of the graft are explained by an impaired clearance function by the diseased liver. They are parallel preoperatively and in the beginning of OLT by increased tcu-PA activity. This may reflect a role of the intrinsic fibrinolytic system in the "hyperfibrinolytic state" observed in patients with end stage liver disease. u-PA Ag and scu-PA normalize following reperfusion. The increase in tcu-PA observed during the anhepatic phase coincided with greatly increased fibrinolysis, as demonstrated by thrombelastography. This indicates that u-PA seems to be involved in the development of fibrinolysis during OLT. It had been demonstrated in previous investigations that a significant increase of t-PA activity was seen in the late anhepatic phase leading to an elevated plasmin generation. Since plasmin is a major activator of scu-PA, a t-PA mediated scu-PA activation would explain the concomitant increase in both plasminogen activators.

摘要

相似文献

1
Changes in urokinase-type plasminogen activator in orthotopic liver transplantation.
Semin Thromb Hemost. 1993;19(3):311-4. doi: 10.1055/s-2007-994050.
2
Evolution of urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA) in orthotopic liver transplantation (OLT).原位肝移植(OLT)中尿激酶型纤溶酶原激活物(u-PA)和组织型纤溶酶原激活物(t-PA)的演变
Thromb Haemost. 1993 Jan 11;69(1):56-9.
3
Fibrinolytic activity during orthotopic liver transplantation with and without aprotinin.
Transplantation. 1994 Dec 27;58(12):1356-60.
4
Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypass.抑肽酶治疗的体外循环心脏手术患者中单链尿激酶型纤溶酶原激活剂(scu-PA)的保护作用。
Thromb Haemost. 1995 May;73(5):825-8.
5
Increased urokinase-type plasminogen activator (u-PA) levels in graft liver perfusate and decreased single chain u-PA activation with higher levels of aprotinin.移植肝灌注液中尿激酶型纤溶酶原激活剂(u-PA)水平升高,且随着抑肽酶水平升高,单链u-PA激活减少。
Thromb Haemost. 1994 Jan;71(1):12-4.
6
Coagulation and fibrinolysis in orthotopic liver transplantation: current views and insights.原位肝移植中的凝血与纤溶:当前观点与见解
Semin Thromb Hemost. 1993;19(3):191-6. doi: 10.1055/s-2007-994025.
7
Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.组织型纤溶酶原激活剂(t-PA)、单链尿激酶型纤溶酶原激活剂(scu-PA)和尿激酶在体外血浆环境中对血凝块溶解不存在协同作用。
Thromb Haemost. 1986 Aug 20;56(1):35-9.
8
Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.组织型纤溶酶原激活物水平降低及尿激酶型纤溶酶原激活物水平升高作为局部炎症的一种表现。
Thromb Haemost. 1992 Aug 3;68(2):180-4.
9
Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.人原位肝移植过程中血浆基质金属蛋白酶-2和基质金属蛋白酶-9及其抑制剂金属蛋白酶组织抑制因子-1和金属蛋白酶组织抑制因子-2。抑肽酶的作用及其与缺血/再灌注损伤的关系。
Thromb Haemost. 2004 Mar;91(3):506-13. doi: 10.1160/TH03-05-0272.
10
Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.某些骨髓增殖性综合征中的纤溶酶原激活剂(组织型纤溶酶原激活剂和尿激酶型纤溶酶原激活剂)及纤溶酶原激活剂抑制剂(PAI - 1和PAI - 2)
Med Sci Monit. 2000 Jul-Aug;6(4):684-91.

引用本文的文献

1
An Observational Study of Hemostatic Profile during Different Stages of Liver Transplant Surgery Using Laboratory-Based Tests and Thromboelastography.一项使用实验室检测和血栓弹力图对肝移植手术不同阶段止血情况的观察性研究。
Anesth Essays Res. 2021 Apr-Jun;15(2):194-201. doi: 10.4103/aer.aer_89_21. Epub 2021 Nov 7.